---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-007204"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:48:05.077365+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro announces 1-for-9 reverse stock split effective May 12 to maintain Nasdaq listing

## Summary
- Shares outstanding reduce from ~7,208,591 to ~800,954 at 1-for-9 ratio.
- Split effective May 12, 2025; trading symbol remains ALZN with new CUSIP 02262M605.
- Reverse split aimed at complying with Nasdaq $1.00 minimum bid price requirement.
- No fractional shares issued; holders of fractional shares will receive cash payment.
- Par value unchanged at $0.0001 per share; all options/warrants proportionally adjusted.

## SEC filing metadata
- accession: 0001214659-25-007204
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465925007204/0001214659-25-007204-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925007204/z572538k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-007204
- JSON: https://secwatch.observer/filing/0001214659-25-007204.json
- Plain text: https://secwatch.observer/filing/0001214659-25-007204.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.